Frequency of p16(INK4A) alterations and k-ras mutations in intrahepatic cholangiocarcinoma of the liver

Gut

Volumn 47, Issue 5, 2000, Pages 721-727

  Tannapfel, A ^a   Benicke, M ^a   Katalinic, A ^b   Uhlmann, D ^a   Kockerling, F ^c   Hauss, J ^a   Wittekind, C ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

^c Department of Surgery   (Germany)

Author keywords

Cholangiocarcinoma; Histopathology; K ras; Methylation; P16; Prognosis

Indexed keywords

PROTEIN P16;

ARTICLE; BILE DUCT CARCINOMA; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; GENE INACTIVATION; GENE MUTATION; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ONCOGENE K RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN METHYLATION; SEQUENCE ANALYSIS;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; CPG ISLANDS; DNA METHYLATION; GENE DELETION; GENES, P16; GENES, RAS; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; MUTATION; POLYMERASE CHAIN REACTION; PROGNOSIS; RETROSPECTIVE STUDIES; SEQUENCE ANALYSIS, DNA;

EID: 0033756536     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.47.5.721     Document Type: Article

References (29)

1. Hepatocellular carcinoma and cholangiocarcinoma
2. Current concepts in metastasis
3. p53 Protein overexpression in cholangiocarcinoma arising in primary sclerosing cholangitis
4. Mutations of the p53 tumor suppressor gene and the ras gene family in intrahepatic cholangiocarcinomas in Japan and Thailand
5. Signaling to Rho GTPases
6. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
7. The INK4 family of cell cycle inhibitors in cancer
8. High frequency of p16INK4A gene alterations in hepatocellular carcinoma
9. p16(INK4) is inactivated by extensive CpG methylation in human hepatocellular carcinoma
10. Germ-line mutations of the p16INK4(MTS1) gene occur in a subset of patients with hepatocellular carcinoma
11. Regulation of DNA methylation by the Ras signaling pathway
12. Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras
13. Histological typing of tumours of the liver, 2nd ed
14. Activation of the c-Ki-ras oncogene in aflatoxin B1-induced hepatocellular carcinoma and adenoma in the rat: Detection by denaturing gradient gel electrophoresis
15. Mutation analyses of KRAS exon 1 comparing three different techniques: Temporal temperature gradient electrophoresis, constant denaturant capillary electrophoresis and allele specific polymerase chain reaction
16. Germline p16 mutations in familial melanoma
17. Expression of p73 and its relation to histopathology and prognosis in hepatocellular carcinoma
18. Expression of p73, a novel protein related to the p53 tumor suppressor gene, and apoptosis in cholangiocellular carcinoma of the liver
19. Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma
20. Mutation spectra resulting from carcinogenic exposure: From model systems to cancer-related genes
21. Genetic epidemiology of mutated K-ras proto-oncogene, altered suppressor genes, and microsatellite instability in colorectal adenomas
22. K-ras mutations in patients with early colorectal cancers
23. Mutations of Ki-ras and p53 genes in colorectal cancer and their prognostic significance
24. Role of the ras-MAPK signaling pathway in the DNA methyltransferase response to DNA hypomethylation
25. Expression of catalytically active telomerase does not prevent premature senescence caused by overexpression of oncogenic Ha-Ras in normal human fibroblasts
26. Association of K-ras mutations with p16 methylation in human colon cancer
27. Role of the INK4a locus in tumor suppression and cell mortality
28. Inhibition of ras-induced proliferation and cellular transformation by p16INK4